ELISA Analyzers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

ELISA Analyzers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The ELISA analyzer market is expected to register a CAGR of 2.3% over the forecast period, 2022-2027.

COVID-19 has had both positive and negative impacts on the market studied. For instance, the demand for ELISA analyzers for COVID-19 testing increased during the pandemic. The rise in demand for ELISA testing in the detection of COVID-19 fueled the growth of the market in the later phase of the pandemic. In addition, various in vitro diagnostic companies launched ELISA test kits for the detection of COVID-19 which required the use of ELISA analyzers. For instance, in August 2021, Zeus Scientific Inc received FDA authorization to use the Dynex Agility, Dynex DSX, or Dynex DS2 Automated ELISA Systems to run the ZEUS ELISA SARS-SoV-2 total antibody test system. Hence, this led to a surge in demand for ELISA analyzers during the pandemic.

However, the ELISA analyzer market also experienced a negative impact during the COVID-19 pandemic as the volume of other infectious disorders such as HIV was reduced. For instance, according to the Minnesota Department of Health, the COVID-19 pandemic resulted in disruptions of HIV testing in Minnesota, United States in the year 2020. Also, according to the Centers for Disease Control and Prevention (CDC), new HIV diagnoses reported to CDC between 2019 to 2020 registered a decline of 17%. Furthermore, it also stated a substantial decline in HIV testing from 2019 to 2020.

In addition, access to clinical services and non-essential laboratory testing for diseases such as dengue, Lyme disease, and others also impacted during the pandemic. This was mainly because the testing laboratories worldwide were preoccupied with COVID-19 testing in the initial phase of the outbreak. For instance, Boston Medical Center published a press release in December 2020. According to this press release, new research from Boston Medical Center reported that decreased in-person hospital visits in the COVID-19 pandemic resulted in a decline in hospital-wide Hepatitis C (HCV) testing by 50%. Furthermore, the research also reported a decrease in new HCV diagnoses by more than 60%. Hence, the worldwide decline in ELISA testing during the pandemic lead to a decline in the demand for ELISA analyzers.

The major factor that leads to the growth of the studied market includes the widespread prevalence of infectious diseases and cancer. Furthermore, other factors such as the rise in demand for automated and portable ELISA systems also drive the growth of the market.

The surge in the prevalence of infectious diseases leads to a rise in demand for ELISA analyzers. For instance, according to an estimate by the World Health Organization (WHO), an estimated 38.4 million people were living with HIV at the end of 2021. Similarly, as of August 2022, the WHO Pan American Health Organization (PAHO) reported 2,141,240 dengue cases in the Americas. Thus, the surge in infectious disease led to a surge in ELSIA testing which in turn led to a surge in demand for ELISA analyzers thereby driving the growth of the market.

Furthermore, ELISA is employed to quantify antibody titers which are used for the evaluation of immunogenicity during vaccine development. Hence, the rise in vaccine development activities across the globe leads to a surge in demand for ELISA analyzers thereby driving the growth of the market. For instance, according to a review by the World Health Organization (WHO), in 2021 there were 112 bacterial vaccine candidates present in the clinical stage of development. Similarly, there were 109 bacterial vaccine candidates present in the preclinical stage of development.

In addition, pharmaceutical companies such as GSK plc. and Sanofi have a substantial number of vaccine candidates in the pipeline. For instance, Sanofi has 10 vaccine candidates in its pipeline according to the latest updates at the Q2 2022 results meeting, which was held in July 2022. Hence, the surge in vaccine developmental activities leads to a rise in demand for ELISA analyzers thereby driving the growth of the market. Howerver, lack of skilled professionals & low detection limit of existing technology is expected to hinder the market growth during the study period.

Key Market TrendsAutomated ELISA Analyzers are Expected to Witness High Growth Over the Forecast Period

Automated ELISA analyzers have various advantages over semi-automated ELISA analyzers. Thus, this makes them a preferred choice in testing laboratories. For instance, automation provides the possibility of a walk-away workflow that saves time. Furthermore, other benefits of automated ELISA analyzers include increased accuracy in results, cost efficiency, and fast turnaround times.

In addition, automation also provides an increase in flexibility. For instance, with the help of software and robotic component, automated analyzers can turn into a flexible workstation that can easily adapt to the required application. Hence, these benefits lead to a surge in their demand thereby driving the growth of the segment.

Other factors such as the high cost of automated ELISA analyzers are another factor that leads to a surge in revenues generated in the segment. In addition, key companies operating in the market are adopting strategies to provide advanced automated ELISA analyzers. This in turn leads to a surge in demand for automated analyzers thereby driving the growth of the segment. For instance, in August 2021, Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH merged with Gold Standard Diagnostics Inc. Furthermore, Gold Standard Diagnostics provides its ELISA automated analyzers through Novatec Immundiagnostica GmbH. Hence these factors drive the growth of the segment.

North America is Expected to Dominate the ELISA Analyzer Market

North America is expected to dominate the market. This is due to the surge in the prevalence of infectious diseases such as HIV, Lyme disease, hepatitis C and others that require ELISA testing. For instance, FAIR Health released a study in August 2022. The study claimed a substantial rise in Lyme disease diagnoses between 2007 to 2021 in both rural and urban areas in the United States. Furthermore, the results of the study indicated that private insurance claims associated with Lyme disease diagnoses increased by 357% in rural areas and 65% in urban areas.

Similarly, according to preliminary data reported by the Centers for Disease Control and Prevention (CDC), there were 101,590 cases of syphilis in 2017 in the United States which reached 171,074 cases of syphilis in 2021. Thus, the surge in prevalence of infectious diseases in the region leads to a surge in demand for ELISA analyzers thereby driving the growth of the market.

Furthermore, factors such as the presence of key players in the region lead to the easy availability of advanced automated ELISA analyzers which in turn contributes to the growth of the market. Some of the key players operating in the region include PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Eurofins Scientific (Eurofins Abraxis), Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), and Awareness Technology, Inc. Therefore, owing to the previously mentioned factors the growth of the market studied is anticipated in the North America Region.

Competitive Landscape

The ELISA analyzer market is consolidated in nature due to the presence of a limited number of companies operating across the globe. The competitive landscape includes an analysis of a few international as well as local companies that operate in the market such as Dynex Technologies Inc, Berthold Technologies GmbH & Co.KG, Grifols, S.A., Eurofins Scientific (Eurofins Abraxis), PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Hamilton Company, BIOLINE Medical System, Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), Awareness Technology, Inc., and Everex S.r.l. among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.